Literature DB >> 6162895

Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).

M P Langford, D A Weigent, J A Georgiades, H M Johnson, G J Stanton.   

Abstract

Antiserum to human gamma interferon (IFN gamma) was produced in rabbits immunized with partially purified (10(4.8) to 10(6.2) antiviral U/mg protein) staphylococcal enterotoxin A-induced IFN gamma. Staphylococcal enterotoxins, phytohemagglutinin M, concanavalin A, and pokeweed mitogen-induced antiviral activity in human leukocyte cultures was neutralized to undetectable levels by the antiserum. However, human leukocyte interferon (IFN alpha), human fibroblast interferon (IFN beta), and mouse interferons were not neutralized by the antiserum. After determining the antiserum was specific for IFN gamma and did not neutralize other known types of interferon, it was used with antibody to human IFN alpha to demonstrate the type(s) of interferon stimulated by some new inducers and antigens. Galactose oxidase- and calcium ionophore-induced interferons were neutralized to undetectable levels by the antiserum to IFN gamma. Interferon produced in leukocyte cultures from tuberculin-negative individuals stimulated with tuberculin-purified protein derivative or old tuberculin was IFN alpha, whereas interferon from tuberculin-positive individuals was a combination of alpha and gamma IFN. In addition, the antiserum neutralized the anticellular and natural killer cell enhancement activities of IFN gamma preparations. The specificity of this antiserum for IFN gamma indicates that it is an additional, powerful tool for identifying and classifying known and new interferons produced in vitro or in vivo and for investigating the role(s) of IFN gamma during the course of infectious, neoplastic, and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6162895

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Gamma-interferon induction in human lymphoblasts compared with fresh mononuclear leucocytes: earlier synthesis, rapid shut-off and enhancement of yields by metabolic inhibitors.

Authors:  M F Wilkinson; A G Morris
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

2.  Production of lymphokines by HBsAg-reactive human T cell clones upon antigenic stimulation.

Authors:  A Nonomura; G Ohta
Journal:  Gastroenterol Jpn       Date:  1987-08

3.  Cellular defenses against Toxoplasma gondii in newborns.

Authors:  C B Wilson; J E Haas
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

4.  Interleukin 2 enhances natural killer cell activity through induction of gamma interferon.

Authors:  D A Weigent; G J Stanton; H M Johnson
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

5.  Induction of human gamma interferon by structurally defined polypeptide fragments of group A streptococcal M protein.

Authors:  D A Weigent; E H Beachey; T Huff; J W Peterson; G J Stanton; S Baron
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

6.  Streptococcus pneumoniae cocultured with fibroblasts enhances both interferon production and cytotoxic activity by lymphocytes.

Authors:  D A Weigent; S Baron; G J Stanton
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Gamma interferon production by combinations of human peripheral blood lymphocytes, monocytes, and cultured macrophages.

Authors:  R D Arbeit; P L Leary; M J Levin
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.

Authors:  M Katano; H Yamamoto; T Mizoguchi; T Hisatsugu
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

9.  Serum interferon in Navajo children with severe combined immunodeficiency disease inhibits lymphoblastogenesis.

Authors:  J F Jones; L M Minnich; D O Lucas; V A Fulginiti; Z Ingham; M P Langford; G J Stanton
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

10.  The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF).

Authors:  M Katano; T Mizoguchi; H Yamamoto; M Nakamura; T Matsuo; T Hisatugu; T Kisu; K Yamaoka; O Tokunaga
Journal:  Jpn J Surg       Date:  1990-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.